Biodexa Pharmaceuticals PLC (BDRX)
4.86
+0.01
(+0.21%)
USD |
NASDAQ |
Nov 14, 16:00
4.50
-0.36
(-7.41%)
After-Hours: 20:00
Biodexa Pharmaceuticals Research and Development Expense (Quarterly)
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
Date | Value |
---|
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
Adaptimmune Therapeutics PLC | 40.45M |
Verona Pharma PLC | 10.55M |
NuCana PLC | 8.540M |
Autolus Therapeutics PLC | 36.61M |
TC BioPharm (Holdings) PLC | 1.648M |